1. Home
  2. IMRN vs SEED Comparison

IMRN vs SEED Comparison

Compare IMRN & SEED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Immuron Limited

IMRN

Immuron Limited

N/A

Current Price

$0.88

Market Cap

7.7M

Sector

Health Care

ML Signal

N/A

Logo Origin Agritech Limited

SEED

Origin Agritech Limited

N/A

Current Price

$0.79

Market Cap

8.5M

ML Signal

N/A

Company Overview

Basic Information
Metric
IMRN
SEED
Founded
1994
1997
Country
Australia
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Farming/Seeds/Milling
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
7.7M
8.5M
IPO Year
2016
2005

Fundamental Metrics

Financial Performance
Metric
IMRN
SEED
Price
$0.88
$0.79
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
22.9K
★ 98.3K
Earning Date
08-28-2026
05-21-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$16.39
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.68
$0.66
52 Week High
$1.99
$1.79

Technical Indicators

Market Signals
Indicator
IMRN
SEED
Relative Strength Index (RSI) 32.67 45.70
Support Level $0.73 $0.68
Resistance Level $0.89 $1.08
Average True Range (ATR) 0.07 0.09
MACD -0.00 -0.00
Stochastic Oscillator 8.30 26.32

Price Performance

Historical Comparison
IMRN
SEED

About IMRN Immuron Limited

Immuron Ltd is a commercial- and clinical-stage biopharmaceutical company focused on the development and commercialization of specifically targeted polyclonal antibodies. Its oral polyclonal antibodies offer delivery within the GI tract and can target viruses or bacteria and neutralize toxins at mucosal surfaces. The Company markets Travelan in Australia, an over-the-counter orally administered passive immunotherapeutic product indicated to reduce the risk of traveler's diarrhea and minor gastrointestinal disorders. Its products include Travelan, ProIBS and Protectyn. Its segments are Research and Development and Hyper-immune products, with Hyper-immune products generating maximum revenue. Australia generates maximum revenue.

About SEED Origin Agritech Limited

Origin Agritech Ltd is a Chinese agricultural technology company operating in the PRC including seed research and development activities featured in crop seed breeding and genetic improvement. The company's phytase corn was the first transgenic corn to receive the Bio-Safety Certificate from China's Ministry of Agriculture. Origin has established a robust biotechnology seed pipeline including products with glyphosate tolerance and pest resistance (Bt) traits.

Share on Social Networks: